MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
15,268 Approvals
Showing 1 to 20 of 15,268 approvalsPage 1 of 764

Glycerol Fructose and Sodium Chloride Injection

Approval Number: 国药准字HC20170004
Registration: Dec 31, 2021

Compound Tremella and Cod Liver Oil

Approval Number: 国药准字H46020579
Registration: Dec 31, 2021

Henagliflozin Proline Tablets

Approval Number: 国药准字H20210052
Registration: Dec 31, 2021

Levetiracetam Concentrated Solution for Injection

Approval Number: 国药准字H20213985
Registration: Dec 31, 2021

Atropine Sulfate Tablets

Approval Number: 国药准字H22023142
Registration: Dec 31, 2021

Aztreonam for Injection

Approval Number: 国药准字H20123111
Registration: Dec 31, 2021

Calcitriol Soft Capsules

Approval Number: 国药准字H20213963
Registration: Dec 31, 2021

Oleanolic Acid Tablets

Approval Number: 国药准字H22023157
Registration: Dec 31, 2021

Levofloxacin Tablets

Approval Number: 国药准字H20213968
Registration: Dec 31, 2021

Oxycodone Hydrochloride Injection

Approval Number: 国药准字H20213987
Registration: Dec 31, 2021

Essential balm

Approval Number: 国药准字Z41021372
Registration: Dec 31, 2021

Lomefloxacin Hydrochloride Cream

Approval Number: 国药准字H10970421
Registration: Dec 31, 2021

氟米龙

Approval Number: 国药准字H20173065
Registration: Dec 31, 2021

Oxygen

Approval Number: 国药准字H20073226
Registration: Dec 31, 2021

Cetrorelix Acetate Powder for Injection

Approval Number: 国药准字H20213977
Registration: Dec 31, 2021

Sulfadiazine Tablets

Approval Number: 国药准字H22023200
Registration: Dec 31, 2021

Letermovir Tablets

Approval Number: 国药准字HJ20210086
Registration: Dec 31, 2021

Tenofovir Disoproxil Fumarate Tablets

Approval Number: 国药准字H20213997
Registration: Dec 31, 2021

Cerebroprotein Hydrolysate Injection

Approval Number: 国药准字H22024509
Registration: Dec 31, 2021

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.